The comparative effects of SE1520, frusemide, and cyclopenthiazide in healthy subjects.
D001549:Benzamides / Q000494:pharmacology; D001581:Benzothiadiazines; D001639:Bicarbonates / Q000097:blood; D001786:Blood Glucose; D002118:Calcium / Q000652:urine; D002712:Chlorides / Q000097:blood / Q000652:urine; D002986:Clinical Trials as Topic; D003499:Cyclic S-Oxides / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology*; D005665:Furosemide / Q000494:pharmacology*; D006801:Humans; D007211:Indoles / Q000494:pharmacology; D011188:Potassium / Q000097:blood / Q000652:urine; D012964:Sodium / Q000652:urine; D049993:Sodium Chloride Symporter Inhibitors / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*; D013997:Time Factors; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014882:Water-Electrolyte Balance
D001549:Benzamides; D001581:Benzothiadiazines; D001639:Bicarbonates; D001786:Blood Glucose; D002712:Chlorides; D003499:Cyclic S-Oxides; D003517:Cyclopentanes; D004232:Diuretics; D007211:Indoles; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; D014527:Uric Acid; D005665:Furosemide; D014508:Urea; D012964:Sodium; D011188:Potassium; D002118:Calcium